Delivery Order SPE2DB20D2014-SPE2DB24FB92E
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,030.40 firm fixed-price delivery order is for the supply of 100-count bottles of the pain medication Endocet 10-325 mg tablets. The contract has an ultimate completion date of April 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,417.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,850.78, is for the delivery of 4,564,005,666 tablets of ENDOCET 10-325 MG, a prescription pain medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENDOCET 10-325 MG TABLET 100S. The contract has a potential value of $4,350.72 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this order, which falls under an existing indefinite delivery contract (IDC) with DLA valued up to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,349.02 contract is for the supply of ENDOCET 10-325 MG TABLET 100S, a prescription medication. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $1,010.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as the prime contractor. This award is part of a larger indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,881.99 firm fixed-price delivery order contract covers the procurement of 4560837481 ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of the major pharmaceutical distribution company Amerisourcebergen Corporation, provides for the delivery of ENDOCET 10-325 MG TABLET 100S to the Department of Defense (DoD). The contract has a ceiling value of $2,719.20 and a completion date of June 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Endocet 10-325 mg tablets to support military treatment programs and facilities. The contract, valued up to $1,087.68, has a performance period through April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS76N, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,350.72 firm fixed-price delivery order is for the supply of 4563789330 ENDOCET 10-325 MG TABLET 100S. The contract has a period of performance through February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB92EDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,586.03 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a medication used for pain management. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 5/15/24 |